Animal health industry exceeds global targets to reduce the need for antibiotics, final roadmap report shows
Key Points:
- 23 of 25 commitments achieved
- US$13.8bn invested in R&D
- 100+ new vaccines
- 1.9M+ medicine users trained
- US$40m in scholarships & grants
Canberra, ACT – Animal Medicines Australia (AMA)
Animal Medicines Australia (AMA) has welcomed the release of the final report from HealthforAnimals’ Roadmap to Reducing the Need for Antibiotics, which shows the global animal health sector has met or exceeded almost all of its 25 commitments (23 of 25) to support responsible antibiotic use and combat antimicrobial resistance (AMR).
The report marks the culmination of a landmark industry initiative launched in 2019, bringing together animal health companies around a shared goal: improving disease prevention and reducing the need for antibiotics through innovation, education and collaboration.
Among the industry’s key achievements highlighted in the report, the animal health sector invested an estimated US$13.8 billion in research and development, exceeding its original target of $10 billion. 109 new vaccines and 52 new diagnostic tools were brought to market, helping veterinarians and producers prevent, detect and manage disease more effectively.
Highlighting the sector’s commitment to education and stewardship, more than 1.9 million medicine users were trained in responsible antibiotic use – far surpassing the original goal of 100,000 people. In addition, close to US$40 million was provided globally through veterinary scholarships and research grants.
AMA CEO Mr Ben Stapley said the results demonstrate the power of prevention-focused approaches in protecting animal health while supporting efforts to address AMR.
“Antibiotics remain a cornerstone of animal health and welfare,” Mr Stapley said.
“Animals, like people, face constant threats from disease, and antibiotics continue to play a critical role in ensuring sick animals can be treated effectively.
“At the same time, antimicrobial resistance is a serious global challenge. That’s why our industry has invested heavily in disease prevention, innovation and education to reduce the need for antibiotics wherever possible.”
Part of a global movement
The Roadmap’s success reflects a broader international shift towards disease prevention as a key strategy in addressing AMR. Similar approaches are now being championed through initiatives such as the Food and Agriculture Organization’s RENOFARM programme, the World Organisation for Animal Health’s global AMR strategy2, and the latest Global Action Plan on Antimicrobial Resistance3.
Importantly, evidence continues to show that prevention-focused strategies are delivering results. Globally, data show significant declines in antibiotic use in animals over recent years.
Commitment continues
While celebrating the achievements of the Roadmap, AMA said ongoing effort will be required to maintain progress and ensure our animals continue to have access to effective antibiotics.
“The Roadmap demonstrates what can be achieved when industry, veterinarians, producers and policymakers work together. We are proud of what has been delivered, but the job is not finished.
“There are still opportunities to further strengthen disease prevention, expand access to innovative tools and continue promoting the responsible use of antibiotics. The lessons from this Roadmap will help guide the next phase of our industry’s contribution to protecting animal and human health.” Mr Stapley said.
- Access the final report: Roadmap to Reducing the Need for Antibiotics
